Freshfields Bruckhaus Deringer is advising CVC Capital Partners, while Wachtell, Lipton, Rosen & Katz, Arthur Cox and A&O Shearman are serving as legal counsel to Mallinckrodt...
You must be a Standard 1 Year member to access this content.
Freshfields advised Novartis on its exclusive license agreement with Arvinas for a potential first-in-class prostate cancer treatment. Novartis, a global healthcare company, has entered into an...
You must be a Standard 1 Year member to access this content.
Freshfields advised Merz Therapeutics on its $185 million acquisition of Acorda Therapeutics. Merz Therapeutics, a renowned entity in the neurotoxins sector, has entered into an agreement...
You must be a Standard 1 Year member to access this content.
Freshfields advised Roivant on Sale of Telavant to Roche. Switzerland’s Roche (ROG.S) has entered into an agreement to pay an initial $7.1 billion to Roivant (ROIV.O)...
You must be a Standard 1 Year member to access this content.
Freshfields advised SERB Pharmaceuticals on its U.S. Partnership. SERB Pharmaceuticals, a global specialty pharmaceutical company, has acquired exclusive US rights to the ticagrelor reversal agent bentracimab...
You must be a Standard 1 Year member to access this content.
